Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Catalaa, I.
Right arrow Articles by McGowan, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Catalaa, I.
Right arrow Articles by McGowan, J. C.
(Radiology. 2000;216:351-355.)
© RSNA, 2000


Neuroradiology

Multiple Sclerosis: Magnetization Transfer Histogram Analysis of Segmented Normal-appearing White Matter1

Isabelle Catalaa, MD, Robert I. Grossman, MD, Dennis L. Kolson, MD, Jayaram K. Udupa, PhD, Laszlo G. Nyul, MSc, Luogang Wei, MS, Xuan Zhang, MD, Marcia Polansky, ScD, Lois J. Mannon, RT and Joseph C. McGowan, PhD

1 From the Department of Radiology, University of Pennsylvania Medical Center, 3400 Spruce St, Philadelphia, PA 19104 (I.C., R.I.G., D.L.K., J.K.U., L.G.N., L.W., X.Z., L.J.M., J.C.M.), and MCP–Hahnemann University, School of Public Health (M.P.). From the 1998 RSNA scientific assembly. Received August 2, 1999; revision requested September 24; revision received December 8; accepted December 16. Supported in part by National Institutes of Health grants NS29029-03/04, 5M01-RR00040-34, NS37172, NS 34353; I.C. supported in part by a grant from the French Society of Radiology. Address correspondence to J.C.M. (e-mail: jmcgowan@seas.upenn.edu).


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
PURPOSE: To investigate and characterize the global distribution of magnetization transfer (MT) ratio values of normal-appearing white matter (NAWM) in patients with relapsing-remitting multiple sclerosis (MS) and test the hypothesis that the MT histogram for NAWM reflects disease progression.

MATERIALS AND METHODS: Conventional and MT magnetic resonance (MR) images were obtained in 23 patients and 25 healthy volunteers. Clinical tests for comparison with the MT histogram parameters included the Extended Disability Status Scale and the ambulation index. Lesion load calculated with T2-weighted MR images and whole-brain and white matter volumes were measured.

RESULTS: The location of the MT histogram peak and the mean MT ratio for NAWM were significantly lower in patients with MS than in control subjects. In longitudinal studies, the histogram peak location and mean MT ratio shifted in the direction of normal values as the duration of disease increased. A mean of 26.5% of the volume of new lesions identified on the later studies were demonstrated to have originated in NAWM corresponding to "lost" pixels on the histogram.

CONCLUSION: MT histogram analysis of NAWM, including longitudinal analysis, may provide new prognostic information regarding lesion formation and increase understanding of the course of the disease.

Index terms: Brain, MR, 10.121411, 10.121412, 10.121417 • Brain, white matter • Magnetic resonance (MR), magnetization transfer, 10.121412, 10.121417 • Sclerosis, multiple, 10.871


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Conventional magnetic resonance (MR) imaging, particularly T2-weighted imaging, is most commonly applied in the neuroradiologic assessment of macroscopic disease burden in patients with multiple sclerosis (MS) (1,2). Nevertheless, this technique is limited by a lack of specificity for the characterization of disease stage and typically provides little insight regarding the course of the disease in an individual patient.

Recently, there has been interest in the characterization of MS with newer MR techniques such as magnetization transfer (MT), with the overarching goal of increased specificity for diagnosis and prognosis. In earlier work (3), up to 72% of macroscopically normal white matter (WM) was shown to be diseased at the microscopic level (3). More recently, normal-appearing WM (NAWM) in patients with MS has been found (46) to be abnormal by means of analysis of both MR imaging and MR spectroscopic findings.

A typical approach for studies involving MT contrast is to compute the mean MT ratio (MTR) values from two-dimensional regions of interest, largely limiting the results to macroscopic disease that is apparent on MR images. A more recent approach (7) was designed to investigate the multifocal and diffuse extent of MS through the generation of histograms of MTR values over the total brain area. Results of this work indicated that the overall distribution of MT values is shifted toward lower values in patients with MS and that the peak height of the MTR histogram, which is thought to reflect the residual amount of normal brain tissue, is significantly lower in patients with MS than in healthy control subjects. The MTR histogram peak height exhibits a negative correlation with disease duration, and a negative correlation between whole-brain MTR histogram peak height and Extended Disability Status Scale (EDSS) score has also been shown in a population of patients whose disease was classified as relapsing-remitting MS (710). A negative correlation between lesion load as calculated from T2-weighted MR images and MTR histogram peak height also was found (10).

In the present study, we focused our investigation on WM that was judged to be normal on conventional MR images obtained with T2-weighted and intermediate-weighted sequences (the latter of which minimizes both T1 and T2 contrast) and obtained MTR histograms restricted to this tissue alone. Our hypothesis was that the distribution of MTR values in NAWM, as demonstrated with the NAWM MTR histogram, would reflect the presence and progression of the disease. We also tested the hypothesis that an MTR abnormality in NAWM would portend development of new lesions.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
We examined 23 patients (19 women and four men aged 27–37 years) in whom a clinical diagnosis of MS had been established on the basis of the criteria of Poser and colleagues (11,12); the disease in these patients was classified as relapsing-remitting MS. None of the patients had been treated with immunosuppressant or immunomodulatory drugs at the time of MR imaging, with the possible exception of corticosteroids administered for exacerbations. The patients underwent conventional and MT MR imaging at 1.5 T (Signa; GE Medical Systems, Milwaukee, Wis). Contiguous transverse 3-mm-thick fast spin-echo intermediate-weighted (repetition time msec/effective echo time msec, 2,000/14) and T2-weighted (3,000/102 [effective]) images were acquired with a 256 x 192 matrix and 22-cm field of view. MT imaging was performed by using a three-dimensional gradient-echo sequence (repetition time msec/echo time msec, 106/5; 12° flip angle) modified by the addition of an MT pulse. The field of view was 22 cm; the matrix size, 128 x 256; and the section thickness, 5 mm. MT contrast was achieved by applying a 19-msec sinc-shaped radio-frequency pulse during each repetition time (13). Two consecutive sets of transverse images were obtained, one with and the other without the MT saturation pulse.

The magnitude of the MT effect was determined by calculating the MTR (4): MTR = [1 - (Ms/M0)] · 100%, where Ms refers to the intensity of a pixel on the MT image and M0 represents the intensity of the corresponding pixel on the control image. This ratio corresponds to the percentage of signal intensity loss due to MT. MTR maps were then produced wherein each pixel intensity value corresponded to the MTR at that location. MT imaging was conducted during two study periods: before and after installation of an imager software update that altered the MT pulse and resulted, during the second period, in reduced MT saturation due to a lower MT pulse amplitude. The pulse offset frequency was 2,000 Hz during period 1 and 1,200 Hz during period 2, when pulse amplitude was described in terms of an effective flip angle of 900°. Ten patients and 18 control subjects were examined in period 1, and 13 patients and seven control subjects were examined in period 2. Care was taken to compare MTR values and derived values only between patients and subjects imaged with identical protocols. We found no substantive difference in the qualitative MT effect between the two periods of the study.

All patients underwent a neurologic examination at the time of MR imaging. The Kurtzke EDSS, ambulation index, and duration of disease (defined according to the date of initial diagnosis) were determined for the patients.

As noted, a total of 25 healthy volunteers whose age covered the same range as that of the patients and who had no history of neurologic problems underwent an identical imaging protocol. Nine patients and six healthy subjects underwent a protocol of two conventional and MT MR imaging studies for the purpose of a longitudinal analysis. The time between the two studies varied from 12 to 32 months (mean, 24 months) for the patients and from 3 to 7 months (mean, 4 months) for the control subjects. All studies were approved by the institutional review board of the University of Pennsylvania, and informed consent was obtained from all patients and subjects.

The T2- and intermediate-weighted MR images were postprocessed for whole-brain segmentation of lesion, WM, and gray matter by using algorithms based on fuzzy connectedness principles reported previously (14,15) and an internal version of the 3DVIEWNIX software system (16). The results of software segmentation of the brain were manually corrected by a trained neuroradiologist (I.C.) to exclude parts of the skull and regions of cerebrospinal fluid that were occasionally included by the algorithms. Lesions (if present), WM, and gray matter were also identified with the software and were used to produce masks that corresponded to the specific tissue types. This technique exhibits 95.5% intrareader reproducibility for the segmentation of WM (and gray matter) on repeated images (Nyul LG, unpublished results, 1998). Identified lesions were confirmed by the neuroradiologist and were excluded from the WM mask to obtain NAWM masks.

Because the T2- and intermediate-weighted images were generally not in perfect registration with the MT images, the former were registered with the latter in three dimensions by using an intensity correlation method (17,18). Because the intensity patterns on the T2-weighted and MT images were relatively similar, we registered each whole set of T2-weighted images with the corresponding set of MT images. The resultant transformation (including translation and rotation in three dimensions) was then applied to the NAWM mask, which was subsequently also scaled to match the bigger voxels of the MT images. This process resulted in a transformed NAWM mask that matched, as accurately as possible, the NAWM region on the MTR maps. Application of the NAWM mask to the MTR maps allowed calculation of the MTR histogram of whole-brain NAWM. The histograms were normalized to the NAWM volume, and the histogram parameters of peak height, peak location, and mean MTR were calculated for each patient and subject. Data from patients and control subjects that corresponded to the two MT imaging protocols (periods 1 and 2) were grouped and processed as outlined subsequently.

We measured the differences between MTR histograms for NAWM in a subset of control subjects and patients who underwent follow-up conventional and MT MR imaging. In each case, a subtraction histogram was generated by subtracting the more recent histogram from the earlier one (Fig 1). Because we used normalized histograms that had equal total areas, the subtraction histogram, as demonstrated in Figures 1 and 2, can be divided into positive and negative sections that are equal in area. All of the subtraction histograms for patients had a general bimodal form (Fig 1), whereas subtraction histograms for healthy subjects did not have a particular form. In patients, the change in the distribution over time was reflected in the area under either the positive or the negative curve sections. We computed the integral of the positive section of the histogram to determine the relative change between the two MT studies. We also measured the maximum and minimum points of the curve.



View larger version (23K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1. Initial (Study 1, thin solid line) and subsequent follow-up (Study 2, dashed line) NAWM MTR histograms and resultant subtraction (Difference, thick solid line) histogram for one patient. The follow-up NAWM MTR histogram is shifted to the right (toward more normal values for disease-free individuals), resulting in a subtraction histogram with a negative normalized pixel count just left of the center. The negative portion of the subtraction histogram corresponds to pixels lost from the distribution in that region. The MTR values in these histograms correspond to those obtained during period 1 of the study.

 


View larger version (32K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2. Initial (Study 1) and subsequent follow-up (Study 2) NAWM histograms and subtraction (Difference) histogram from a healthy volunteer. The subtraction histogram does not exhibit the characteristic bimodal pattern seen in patients with MS, as exemplified in Figure 1. Instead, its magnitude is less, and the leftmost section is positive. The MTR values in these histograms correspond to those obtained during period 2 of the study.

 
We hypothesized that regions of greater MTR abnormality would be more susceptible to transformation to lesion and noted that, in the patient studies, the negative portion of the subtraction histogram was on the lower-MTR (greater abnormality) side of the histogram. Thus, the negative portion of the subtraction histogram reflected NAWM pixels lost to the lesion distribution, as well as pixels shifted to higher MTR values within the NAWM distribution. We identified pixels represented in the negative portion of the subtraction histogram and tested them for coincidence with new lesions identified with the segmentation process described earlier. On the basis of the number of pixels so identified and of the standard voxel dimension, we calculated the volume of NAWM that became lesion between the first and second study.

We compared MTR histogram parameters between patients and control subjects for periods 1 and 2 by using the Wilcoxon rank sum test for independent samples. When two studies were available, only the earlier was used for this comparison. We compared changes between successive studies in patients and control subjects by using the Wilcoxon signed rank test for paired data. We performed Spearman correlations between MTR histogram parameters and EDSS score, ambulation index, age, and disease duration, as well as lesion load on T2-weighted images and brain and WM volumes; again, only the first of multiple studies was used.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In both periods 1 and 2 of the study, peak location and mean MTR in the NAWM histograms were significantly different between patients and subjects, as summarized in the Table and depicted in Figure 3 for period 2. No significant difference was found between the histogram peak heights for patients and control subjects. In addition, no correlations were found between the NAWM MTR histogram parameters and EDSS score, ambulation index, age, disease duration, or volumetric MR imaging data.



View larger version (26K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3. Histograms for grouped mean NAWM MTR in patients and healthy volunteers in period 2 of the study. NAWM in patients is characterized by a lower mean MTR and a left-shifted peak location.

 
In the longitudinal analysis of patients in whom initial and follow-up studies were obtained, we observed a change in the histogram peak location (P = .03), with no concomitant changes in EDSS score, WM volume, or brain volume. The area under the curve of the subtraction histogram was significantly different between patients and subjects (P < .002). Significant differences were also found between patients and subjects for maximum (P < .002) and minimum (P < .01) points of this histogram. The volume of NAWM corresponding to pixels lost from the distribution on initial studies and associated with new lesions on follow-up studies varied from 33 to 1,674 mm3, (mean, 375 mm3), which represented 0%–44.7% (mean, 26.5%) of the total volume of new lesions.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Our study was motivated by previous work demonstrating that the MTR is abnormally low in the NAWM of patients with MS (4), which is consistent with results of histopathologic analysis (3), and by results of previous histogram analyses (7,8) that suggested that inclusion of non–lesion-containing brain tissue can improve the assessment of global disease state in patients with MS. The relationship between any imaging parameters and clinical status in patients with MS remains cloudy despite some previous encouraging results with MT imaging (19) and MTR histogram analyses (9,10).

Our present—largely negative—results with regard to correlation between NAWM MTR histogram parameters and clinical measures underscore that both microscopic and macroscopic assessments of cerebral disease burden must be included in a global index of disease status. In addition, there is recent evidence (20) supporting the argument for inclusion of gray matter abnormalities for recognition of neuronal loss associated with MS and the potential for "disconnection" of pathways due to WM disease. We note that the previous histogram analyses (7,8) took into account gray matter involvement as part of the whole-brain analysis. Atrophy in gray matter may yet be found to play an important role, and spinal cord involvement certainly has a large influence on clinical assessment (21). Thus, the present results and the techniques discussed in this report may offer the most value in terms of increased understanding of the natural history of the disease and of methods for further probing the prognostic implications.

Results of both phases of this study clearly indicate that the NAWM histogram differed between normal brains and those of patients with MS. Our observations in NAWM may reflect the pathologic processes occurring microscopically therein, including demyelination, edema, and gliosis. Previous results (4,2224) have suggested that MTR can serve as an index of demyelination, and the results of a study of feline wallerian degeneration in visual pathways (25) established a relationship between a biphasic response of MTR and histopathologic findings at electron microscopy.

Our results are in contrast, to some degree, with those reported for whole-brain histograms. In particular, the normalized peak height of the NAWM histogram was not different between patients and control subjects, whereas in the whole-brain histogram (7,8), this parameter was shown to be reliably different. An explanation for this finding may be the inclusion of lesion pixels in the whole-brain histograms, which causes a profound depression of the peak.

In the comparative analysis of paired studies, we noted that, over time, the histogram distributions shifted to the right toward more normal values. This can be seen in the shape of the subtraction histogram, which in patients always was characterized by a negative-valued curve on the left and a corresponding curve to the right on the positive side of the abscissa (Fig 1). Subtraction histograms in healthy subjects did not follow a regular pattern and were smaller in magnitude, consistent with the expected absence of change from study to study (Fig 2).

The areas of the positive and negative sections of the subtraction histogram were equalized by means of the normalization process, which enabled us to study the distribution of values as opposed to raw pixel counts. In patients, the magnitude of the area under the negative portion of the curve corresponded to fewer pixels with lower MTR values in the second study, which represented an evolution toward normal values. The height of the subtraction histogram contained information about the distribution of the "shifted" pixels and might be useful in the discrimination of disease processes, although the preliminary nature of the present data precludes establishment of this contention. We speculated that the "lost" low-MTR pixels would represent a substantial volume of WM that became lesions, but we found that the fraction was variable and, in some cases, very small. An alternative explanation for the finding could be that the regions of NAWM associated with lost pixels were transiently edematous, particularly around lesions that existed at the time of the first study. Edema is known to be characterized by lower MTR values (4,26) and, thus, could have contributed to lower MTRs in NAWM in the first of any pair of studies. Resolution of this edema in the second study could then help explain the higher and more normal values of MTR in the second study. One might expect, however, that the process could occur in either direction and would not have an overall influence on the results. The question remains unresolved and is suggested for future study.

The results of our analysis with regard to the origin of new lesions are suggestive of a link between MTR abnormality in NAWM and subsequent development of lesions. Our results are consistent with some previous results (27,28) but not with others (29). This seeming discrepancy is, perhaps, reflected in the wide variation among the data. The issue remains unresolved and is deserving of further studies, which may provide more insight into the natural course of the disease.

In conclusion, our results add to the information on characterization of NAWM abnormality associated with MS and demonstrate that such abnormality may be explored in terms of the distribution of MTR values. Our results in a small sample indicate that the NAWM distribution of MTR values became closer to the control (disease-free) distribution over time, an unexpected finding that suggests the need for future study and leads to speculation on the nature of evolution from NAWM to lesion. Some regions of NAWM may be "at risk" for the development of new lesions, while other NAWM regions may be stable with regard to MS, although the histogram technique does not appear to help distinguish between those tissue types in an obvious manner. Rather, the future value of the technique may lie in providing an estimate of the degree to which the disease has progressed.

We speculate that although inclusion of gray matter changes and spinal cord involvement may be essential for full characterization of the disease, MT histogram analysis of NAWM, including longitudinal analysis, may provide new prognostic information regarding lesion formation, as well as increased understanding of the disease course. An improved understanding may further the evaluation of novel treatment strategies and pharmaceutical agents for which the preservation of NAWM could be essential.


View this table:
[in this window]
[in a new window]

 
Comparison of NAWM MTR Histogram Parameters in Patients with MS and in Healthy Subjects
 


    FOOTNOTES
 
Abbreviations: EDSS = Extended Disability Status Scale, MS = multiple sclerosis, MT = magnetization transfer, MTR = MT ratio, NAWM = normal-appearing white matter, WM = white matter

Author contributions: Guarantor of integrity of entire study, J.C.M.; study concepts, R.I.G., J.C.M., J.K.U.; study design, R.I.G., J.C.M., J.K.U., D.L.K.; definition of intellectual content, J.C.M.; literature research, I.C., J.K.U.; clinical studies, I.C., D.L.K.; data acquisition, I.C., L.J.M.; data analysis, I.C., L.W., L.G.N., X.Z.; statistical analysis, M.P., J.C.M.; manuscript preparation, I.C., J.C.M.; manuscript editing, J.C.M., R.I.G., J.K.U.; manuscript review, R.I.G., J.K.U.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Grossman R, McGowan J. Perspectives on multiple sclerosis. AJNR Am J Neuroradiol 1998; 19:1251-1265.[Medline]
  2. Jackson JA, Leake DR, Schneiders NJ, et al. Magnetic resonance imaging in multiple sclerosis: results in 32 cases. AJNR Am J Neuroradiol 1985; 6:171-176.[Abstract]
  3. Allen I, McKeown S. A histological histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979; 41:81-91.[Medline]
  4. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992; 182:483-491[Erratum: Radiology 1992; 183:878.].[Abstract/Free Full Text]
  5. Hiehle JF, Jr, Lenkinski RE, Grossman RI, et al. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis. Magn Reson Med 1994; 32:285-293.[Medline]
  6. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995; 45:478- 482.[Abstract/Free Full Text]
  7. van Buchem MA, Udupa JK, McGowan JC, et al. Global volumetric estimation of disease burden in multiple sclerosis based on magnetization transfer imaging. AJNR Am J Neuroradiol 1997; 18:1287-1290.[Abstract]
  8. van Buchem MA, McGowan JC, Kolson DL, Polansky M, Grossman RI. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996; 36:632-636.[Medline]
  9. van Buchem MA, Grossman RI, Armstrong C, et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 1998; 50:1609-1617.[Abstract]
  10. Miki Y, Grossman R, Udupa J, et al. Differences between relapsing-remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging. Radiology 1999; 210:769-774.[Abstract/Free Full Text]
  11. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13:227-231.[Medline]
  12. Poser CM. Diagnostic criteria for multiple sclerosis: an addendum (letter). Ann Neurol 1987; 22:773.
  13. McGowan JC, Schnall MD, Leigh JS. Magnetization transfer imaging with pulsed off-resonance saturation: contrast variation with saturation duty cycle. J Magn Reson 1994; 4:79-82.
  14. Udupa J, Wei L, Samarasekera S, Miki Y, van Buchem M, Grossman R. Multiple sclerosis lesion quantification using fuzzy connectedness principles. IEEE Trans Med Imaging 1997; 16:598-609.[Medline]
  15. Udupa J, Samarasekera S. Fuzzy connectedness and object definition: theory, algorithms and applications in image segmentation. Graphical Models and Image Processing 1996; 58:246-261.
  16. Udupa J, Odhner O, Samarasekera S, et al. 3DVIEWNIX: an open, transportable, multidimensional, multimodality, multiparametric imaging software system. Proc SPIE 1994; 2164:58-73.
  17. Woods RP, Cherry SR, Mazziotta JC. A rapid automated algorithm for accurately aligning and reslicing PET images. J Comput Assist Tomogr 1992; 16:620-633.[Medline]
  18. Palagyi K, Udupa J. Medical image registration based on fuzzy objects (abstr) In: Proceedings of COMBIO 1996 summer workshop on computational modeling, imaging and visualization in biosciences. Budapest, Hungary: Central Research Institute for Physics, 1996; 44-48.
  19. Gass A, Barker GJ, Kidd D, et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 1994; 36:62-67.[Medline]
  20. Trapp B, Peterson J, Ransohoff R, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338:278-285.[Abstract/Free Full Text]
  21. Comi G, Filippi M, Martinelli V, et al. Brain stem magnetic resonance imaging and evoked potential studies of symptomatic multiple sclerosis patients. Eur Neurol 1993; 33:232-237.[Medline]
  22. Tomiak MM, Rosenblum JD, Prager JM, Metz CE. Magnetization transfer: a potential method to determine the age of multiple sclerosis lesions. AJNR Am J Neuroradiol 1994; 15:1569-1574.[Abstract]
  23. Hiehle JF, Jr, Grossman RI, Ramer KN, Gonzalez-Scarano F, Cohen JA. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol 1995; 16:69-77.[Abstract]
  24. McGowan JC, Haskins ME, Wenger DA, Vite CH. Investigating demyelination in the brain in a canine model of globoid cell leukodystrophy (Krabbe disease) using magnetization transfer contrast. J Comput Assist Tomogr 2000; 24:316-321.[Medline]
  25. Lexa FJ, Grossman RI, Rosenquist AC. MR of wallerian degeneration in the feline visual system: characterization by magnetization transfer rate with histopathologic correlation. AJNR Am J Neuroradiol 1994; 15:201-212.[Abstract]
  26. Mehta RC, Pike GB, Enzmann DR. Measure of magnetization transfer in multiple sclerosis demyelinating plaques, white matter ischemic lesions, and edema. AJNR Am J Neuroradiol 1996; 17:1051-1055.[Abstract]
  27. Filippi M, Rocca MA, Martino G, Horsfield MA, Comi G. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998; 43:809-814.[Medline]
  28. Goodkin D, Rooney W, Sloan R, et al. A serial study of new MS lesions and the white matter from which they arise. Neurology 1998; 51:1689-1697.[Abstract/Free Full Text]
  29. Silver N, Lai M, Symms M, McDonald W, Miller D. Serial magnetization transfer imaging to characterize the early evolution of new MS lesions. Neurology 1998; 51:758-764.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Mult SclerHome page
H. Vrenken, P.J.W. Pouwels, S. Ropele, D.L. Knol, J.J.G. Geurts, C.H. Polman, F. Barkhof, and J.A. Castelijns
Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease
Multiple Sclerosis, July 1, 2007; 13(6): 708 - 716.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
H. Vrenken, J.J.G. Geurts, D.L. Knol, C.H. Polman, J.A. Castelijns, P.J.W. Pouwels, and F. Barkhof
Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis.
AJNR Am. J. Neuroradiol., October 1, 2006; 27(9): 2005 - 2011.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
Y. Ge
Multiple Sclerosis: The Role of MR Imaging
AJNR Am. J. Neuroradiol., June 1, 2006; 27(6): 1165 - 1176.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S. C.-Y. Chen, H.-W. Chung, and M. Liou
Measurement of Volumetric Lesion Load in Multiple Sclerosis: Moving from Normal- to Dirty-Appearing White Matter
AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1929 - 1930.
[Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
Y. Ge, R. I. Grossman, J. S. Babb, J. He, and L. J. Mannon
Dirty-Appearing White Matter in Multiple Sclerosis: Volumetric MR Imaging and Magnetization Transfer Ratio Histogram Analysis
AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1935 - 1940.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. J. Lowe, M. D. Phillips, J. T. Lurito, D. Mattson, M. Dzemidzic, and V. P. Mathews
Multiple Sclerosis: Low-Frequency Temporal Blood Oxygen Level-Dependent Fluctuations Indicate Reduced Functional Connectivity—Initial Results
Radiology, July 1, 2002; 224(1): 184 - 192.
[Abstract] [Full Text]


Home page
Am. J. Neuroradiol.Home page
A. C. Guo, V. L. Jewells, and J. M. Provenzale
Analysis of Normal-Appearing White Matter in Multiple Sclerosis: Comparison of Diffusion Tensor MR Imaging and Magnetization Transfer Imaging
AJNR Am. J. Neuroradiol., November 1, 2001; 22(10): 1893 - 1900.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
R. L. P. Lindberg, C. J. A. De Groot, L. Montagne, P. Freitag, P. van der Valk, L. Kappos, and D. Leppert
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis
Brain, September 1, 2001; 124(9): 1743 - 1753.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Catalaa, I.
Right arrow Articles by McGowan, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Catalaa, I.
Right arrow Articles by McGowan, J. C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE